On June 6, 2025, Tectonic Therapeutic, Inc. held its Annual General Meeting, where shareholders elected Alise Reicin, M.D. and Praveen Tipirneni, M.D. as directors, approved Deloitte & Touche LLP as auditors for 2025, and supported the compensation of named executives. The meeting also indicated shareholders prefer annual votes on executive compensation.